We are live on ! Find out more
EBACW

European Biotech Acquisition Corp. Warrant
EBACW

Delisted

EBACW was delisted on the 2nd of March, 2023.

32 hedge funds and large institutions have $2.73M invested in European Biotech Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more capital invested

Capital invested by funds: $932K → $2.73M (+$1.8M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

7% more funds holding

Funds holding: 3032 (+2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
2
Closed
3
Calls
$1.08M
Puts
Net Calls
+$1.08M
Net Calls Change
-$13K
Name Holding Trade Value Shares
Change
Change in
Stake
MP
1
Mangrove Partners
Connecticut
$1.84M +$31.8K +187,740 New
RCM
2
Radcliffe Capital Management
Pennsylvania
$653K
AGC
3
Angelo Gordon & Co
New York
$131K +$2.26K +13,333 New
PC
4
Periscope Capital
Ontario, Canada
$15K
MI
5
MMCAP International
Cayman Islands
$11K
PMAM
6
Picton Mahoney Asset Management
Ontario, Canada
$9K
ACA
7
Arena Capital Advisors
California
$7K
SC
8
Sculptor Capital
New York
$7K
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$6K
MCM
10
Moore Capital Management
New York
$6K
FTCM
11
Fir Tree Capital Management
New York
$5K -$62 -366 -0.7%
TCM
12
Tenor Capital Management
New York
$5K
WP
13
Woodline Partners
California
$5K
CCM
14
CAAS Capital Management
New York
$5K +$5.64K +33,333 New
GF
15
Gabelli Funds
New York
$4K
LA
16
Linden Advisors
New York
$4K
DCM
17
Dupont Capital Management
Delaware
$3K
GCIA
18
Gabelli & Co Investment Advisers
New York
$3K
WA
19
Whitebox Advisors
Minnesota
$3K
AA
20
AQR Arbitrage
Connecticut
$2K
ACM
21
Atalaya Capital Management
New York
$2K
DCM
22
Difesa Capital Management
New York
$2K
State of Wisconsin Investment Board
23
State of Wisconsin Investment Board
Wisconsin
$2K
KL
24
KIM LLC
Kansas
$2K +$2.82K +16,666 New
DC
25
Dryden Capital
Florida
$1K

EBACW Hedge Fund Activity: Q2 2022 in Review

32 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q2 2022, worth a combined $2.73M — up 193% from $932K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new EBACW positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Mangrove Partners, opening a new position worth an estimated $31.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $61K sold.

  • 32 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $2.73M of European Biotech Acquisition Corp. Warrant stock for Q2 2022, up 193% quarter-over-quarter.
  • 5 funds opened new European Biotech Acquisition Corp. Warrant positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest European Biotech Acquisition Corp. Warrant buyer in Q2 2022 was Mangrove Partners, an estimated $31.8K added.
  • The largest European Biotech Acquisition Corp. Warrant seller in Q2 2022 was Citadel Advisors, an estimated $61K sold.

Based on aggregated 13F filings for Q2 2022.